# The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR

> **NCT05478967** · NA · COMPLETED · sponsor: **Peking University People's Hospital** · enrollment: 154 (actual)

## Conditions studied

- Proliferative Diabetic Retinopathy

## Interventions

- **PROCEDURE:** IVA injection before vitrectomy

## Key facts

- **NCT ID:** NCT05478967
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-08
- **Primary completion:** 2021-01-20
- **Final completion:** 2021-02-20
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478967, "The Effect of IVA for Preventing Postvitrectomy Hemorrhage in PDR". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05478967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*